Inventiva announces design of Phase III clinical trial with Ianifibranor in NASH
- 2021.02.04
- NEWS RELEASE
Inventiva (France) has announced design of Phase III clinical trial with Ianifibranor in NASH
For detail information, see the Inventiva's press release.